Experiences with an MCT-containing parenteral nutrition regimen in patients receiving routine TPN.
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004338:Drug Combinations / Q000008:administration & dosage / Q000627:therapeutic use; D005217:Fat Emulsions, Intravenous / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007657:Ketone Bodies / Q000097:blood; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D010289:Parenteral Nutrition, Total; D010743:Phospholipids / Q000008:administration & dosage / Q000627:therapeutic use*; D011446:Prospective Studies; D011897:Random Allocation; D013012:Sorbitol / Q000008:administration & dosage / Q000627:therapeutic use*; D014280:Triglycerides / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D014508:Urea / Q000652:urine
D004338:Drug Combinations; D005217:Fat Emulsions, Intravenous; D007657:Ketone Bodies; D010743:Phospholipids; D014280:Triglycerides; C008288:Lipofundin; D013012:Sorbitol; D014508:Urea